Abstract
Context
Objectives
Methods
Results
Conclusion
Key Words
Introduction
Alzheimer's Association. 2009 Alzheimer's disease facts and figures. Available from wwwalzorg/national/documents/report_alzfactsfigures2009pdf. Accessed March 18, 2010.
Methods
Sample
Outcomes and Independent Variables
Dartmouth Atlas of Health Care. Available from http://www.dartmouthatlas.org/. Accessed March 18, 2010.
Statistical Analysis
Results
Sample Description
Groups of Hospitals | No. of Hospitals in Each Group | No. of Feeding Tube Insertions per 100 Hospital Admissions During 2000–2003 | No. of Feeding Tube Insertions per 100 Hospital Admissions During 2004–2007 |
---|---|---|---|
n (%) | Mean (SD) | Mean (SD) | |
Group 1: low-low | 328 (18.50) | 1.82 (1.54) | 1.23 (1.28) |
Group 2: low-med | 207 (11.68) | 2.21 (1.44) | 5.05 (1.20) |
Group 3: low-high | 62 (3.50) | 2.58 (1.50) | 10.97 (3.48) |
Group 4: med-low | 199 (11.22) | 6.33 (1.20) | 1.59 (1.16) |
Group 5: med-med | 228 (12.86) | 6.60 (1.20) | 5.48 (1.27) |
Group 6: med-high | 159 (8.97) | 6.82 (1.34) | 11.44 (3.90) |
Group 7: high-low | 70 (3.95) | 12.20 (2.98) | 1.7 (1.20) |
Group 8: high-med | 154 (8.69) | 12.61 (3.20) | 5.79 (1.14) |
Group 9: high-high | 366 (20.64) | 14.73 (4.68) | 13.09 (4.72) |
Association of Individual and Hospital Characteristics With Variation in the Rates of Feeding Tube Insertion
Subgroups of Hospitals | 1: Low-Low | 2: Low-Med | 3: Low-High | 4: Med-Low | 5: Med-Med | 6: Med-High | 7: High-Low | 8: High-Med | 9: High-High | P-value |
---|---|---|---|---|---|---|---|---|---|---|
Individual Characteristics (total number of individuals=56,824) | ||||||||||
No. of individuals | n=8359 | n=6311 | n=1537 | n=6538 | n=9065 | n=5183 | n=1906 | n=5220 | n=12,705 | |
Age at assessment (years) | 84.00 (7.31) | 84.20 (7.48) | 84.07 (7.26) | 84.16 (7.35) | 84.31 (7.42) | 83.85 (7.57) | 84.11 (7.59) | 84.07 (7.39) | 83.80 (7.80) | <0.01 |
African American | 5.31% | 7.59% | 17.44% | 8.50% | 9.51% | 15.90% | 10.13% | 15.52% | 24.13% | <0.01 |
Male | 32.71% | 32.10% | 31.10% | 30.90% | 31.21% | 31.82% | 31.43% | 31.93% | 33.02% | 0.06 |
Severe functional impairment (ADL=28) | 12.98% | 14.04% | 16.85% | 14.38% | 14.35% | 15.86% | 13.17% | 14.66% | 17.73% | <0.01 |
CPS=6 | 16.64% | 17.27% | 21.21% | 17.85% | 18.41% | 18.89% | 16.53% | 17.93% | 20.39% | <0.01 |
Presence of legal guardian | 6.15% | 5.64% | 4.75% | 4.83% | 4.99% | 5.05% | 4.93% | 4.75% | 4.62% | <0.01 |
Do not resuscitate | 63.58% | 58.04% | 46.91% | 57.45% | 52.04% | 44.82% | 54.46% | 43.28% | 37.23% | <0.01 |
Feeding restriction | 7.30% | 7.48% | 5.34% | 7.42% | 5.44% | 4.19% | 4.30% | 4.77% | 4.29% | <0.01 |
Congestive heart failure | 19.46% | 18.65% | 18.87% | 19.04% | 18.80% | 18.70% | 19.83% | 19.96% | 18.39% | 0.33 |
Emphysema/COPD | 13.69% | 12.90% | 13.34% | 12.85% | 12.83% | 12.70% | 15.48% | 13.10% | 12.47% | 0.02 |
Stroke | 21.78% | 23.12% | 23.36% | 22.48% | 24.16% | 24.19% | 23.14% | 23.72% | 24.73% | <0.01 |
Cancer | 3.45% | 3.63% | 3.12% | 3.12% | 3.19% | 3.57% | 2.89% | 3.16% | 3.23% | 0.59 |
Renal failure | 2.99% | 3.28% | 3.06% | 3.26% | 2.78% | 2.91% | 2.94% | 3.39% | 3.34% | 0.34 |
Pneumonia/respiratory infection | 8.72% | 8.13% | 9.11% | 8.01% | 8.48% | 7.87% | 7.61% | 7.93% | 7.26% | <0.01 |
CHESS scale (range 0–5) | 1.63 (1.20) | 1.63 (1.21) | 1.53 (1.20) | 1.59 (1.20) | 1.54 (1.20) | 1.49 (1.16) | 1.61 (1.20) | 1.49 (1.17) | 1.36 (1.15) | <0.01 |
The interval between assessment in the MDS and the admission date (days) | 43.63 (39.30) | 43.25 (39.26) | 43.31 (39.41) | 43.14 (39.53) | 42.54 (39.21) | 42.55 (39.66) | 44.30 (40.43) | 42.19 (39.46) | 42.05 (39.14) | <0.01 |
Admitted from nursing homes with chain membership | 58.62% | 56.39% | 65.78% | 54.76% | 52.80% | 53.52% | 60.91% | 54.52% | 46.60% | <0.01 |
Admitted from for-profit nursing homes | 66.89% | 69.93% | 74.11% | 70.91% | 72.02% | 72.43% | 73.14% | 73.51% | 73.31% | <0.01 |
Principal diagnosis of hospital admission | ||||||||||
Pneumonia and other disease of lung | 20.04% | 19.25% | 19.13% | 18.95% | 18.51% | 18.31% | 17.94% | 17.57% | 17.28% | <0.01 |
Septicemia | 9.53% | 10.44% | 13.53% | 11.01% | 11.88% | 12.21% | 11.96% | 13.05% | 13.31% | <0.01 |
Other disorders of urethra and urinary tract | 8.12% | 8.46% | 9.24% | 8.66% | 8.80% | 8.45% | 7.87% | 8.28% | 8.34% | 0.71 |
Disorder of fluid, electrolyte, and acid-base balance | 4.69% | 4.61% | 5.53% | 4.57% | 4.73% | 5.44% | 4.77% | 4.73% | 5.26% | 0.13 |
Fracture of neck of femur | 6.34% | 5.83% | 4.55% | 6.13% | 5.33% | 5.31% | 5.19% | 4.06% | 3.31% | <0.01 |
Heart failure | 4.10% | 3.31% | 3.71% | 3.49% | 3.77% | 3.36% | 3.15% | 3.75% | 3.21% | 0.04 |
General symptoms | 2.46% | 2.38% | 1.89% | 2.68% | 2.99% | 2.80% | 2.78% | 2.55% | 3.14% | <0.01 |
Acute renal failure | 4.04% | 4.02% | 3.97% | 4.14% | 4.27% | 3.90% | 4.25% | 4.62% | 4.25% | 0.77 |
Acute myocardial infarction | 2.20% | 1.93% | 2.02% | 2.37% | 2.17% | 1.95% | 2.26% | 1.93% | 2.00% | 0.65 |
Hospital Characteristics (total number of hospitals=1773) | ||||||||||
No. of hospitals | n=328 | n=207 | n=62 | n=199 | n=228 | n=159 | n=70 | n=154 | n=365 | |
Hospice days per decedent during end-of-life care (days) | 12.00 (3.76) | 12.61 (4.12) | 13.92 (4.64) | 12.30 (3.89) | 12.52 (4.11) | 13.32 (4.64) | 11.85 (3.06) | 12.93 (4.30) | 11.86 (4.33) | <0.01 |
Profit status | 11.59% | 13.53% | 16.13% | 15.08% | 13.60% | 22.01% | 12.86% | 18.18% | 23.22% | <0.01 |
Urban location | 66.06% | 73.91% | 70.97% | 81.41% | 84.65% | 80.25% | 78.57% | 86.67% | 88.42% | <0.01 |
Variation in Hospital Feeding Tube Insertion Rates and Mortality
Group 1: Low-Low as Reference | Group 2: Low-Med | Group 3: Low-High | Group 4: Med-Low | Group 5: Med-Med | Group 6: Med-High | Group 7: High-Low | Group 8: High-Med | Group 9: High-High |
---|---|---|---|---|---|---|---|---|
One-month mortality (no. of individuals=56,824, no. of facilities=1773) OR (95% CI) | ||||||||
Model 1 a Model 1 adjusted for year trend; Model 2 additionally adjusted for sociodemographic characteristics (age, gender, race), advance directives (i.e., do not resuscitate, feeding restriction) and presence of legal guardian, activities of daily living (ADL) score, cognitive performance score (CPS), changes in Health, End-Stage Disease and Symptoms and Signs (CHESS) score, comorbidities (congestive heart failure, cancer, chronic obstructive pulmonary disease, stroke, cancer, renal failure, pneumonia or respiratory infection), time interval between the MDS assessment and the hospital admission and the characteristics of nursing homes from which residents were transferred (i.e., ownership status and chain membership), and additional hospital characteristics (i.e., ownership status, urban location, and hospice days per decedent during end-of-life care). | 1.020 (0.941, 1.104) | 0.957 (0.838, 1.092) | 0.999 (0.923, 1.082) | 0.999 (0.928, 1.076) | 0.937 (0.860, 1.021) | 1.059 (0.939, 1.194) | 1.000 (0.918, 1.089) | 0.861 (0.804, 0.922) |
Model 2 a Model 1 adjusted for year trend; Model 2 additionally adjusted for sociodemographic characteristics (age, gender, race), advance directives (i.e., do not resuscitate, feeding restriction) and presence of legal guardian, activities of daily living (ADL) score, cognitive performance score (CPS), changes in Health, End-Stage Disease and Symptoms and Signs (CHESS) score, comorbidities (congestive heart failure, cancer, chronic obstructive pulmonary disease, stroke, cancer, renal failure, pneumonia or respiratory infection), time interval between the MDS assessment and the hospital admission and the characteristics of nursing homes from which residents were transferred (i.e., ownership status and chain membership), and additional hospital characteristics (i.e., ownership status, urban location, and hospice days per decedent during end-of-life care). | 1.016 (0.933, 1.105) | 0.958 (0.832, 1.104) | 0.996 (0.915, 1.084) | 0.999 (0.923, 1.081) | 0.972 (0.886, 1.066) | 1.084 (0.954, 1.233) | 1.008 (0.919, 1.106) | 0.933 (0.865, 1.007) |
Six-month mortality (no. of individuals=52,802, no. of facilities=1773) OR (95% CI) | ||||||||
Model 1 a Model 1 adjusted for year trend; Model 2 additionally adjusted for sociodemographic characteristics (age, gender, race), advance directives (i.e., do not resuscitate, feeding restriction) and presence of legal guardian, activities of daily living (ADL) score, cognitive performance score (CPS), changes in Health, End-Stage Disease and Symptoms and Signs (CHESS) score, comorbidities (congestive heart failure, cancer, chronic obstructive pulmonary disease, stroke, cancer, renal failure, pneumonia or respiratory infection), time interval between the MDS assessment and the hospital admission and the characteristics of nursing homes from which residents were transferred (i.e., ownership status and chain membership), and additional hospital characteristics (i.e., ownership status, urban location, and hospice days per decedent during end-of-life care). | 1.071 (0.994, 1.154) | 0.946 (0.838, 1.069) | 1.009 (0.937, 1.086) | 1.011 (0.945, 1.083) | 0.997 (0.921, 1.079) | 1.064 (0.950, 1.191) | 1.014 (0.937, 1.098) | 0.953 (0.895, 1.015) |
Model 2 a Model 1 adjusted for year trend; Model 2 additionally adjusted for sociodemographic characteristics (age, gender, race), advance directives (i.e., do not resuscitate, feeding restriction) and presence of legal guardian, activities of daily living (ADL) score, cognitive performance score (CPS), changes in Health, End-Stage Disease and Symptoms and Signs (CHESS) score, comorbidities (congestive heart failure, cancer, chronic obstructive pulmonary disease, stroke, cancer, renal failure, pneumonia or respiratory infection), time interval between the MDS assessment and the hospital admission and the characteristics of nursing homes from which residents were transferred (i.e., ownership status and chain membership), and additional hospital characteristics (i.e., ownership status, urban location, and hospice days per decedent during end-of-life care). | 1.067 (0.987, 1.154) | 0.934 (0.820, 1.063) | 1.005 (0.929, 1.087) | 1.016 (0.945, 1.093) | 1.020 (0.937, 1.110) | 1.085 (0.963, 1.224) | 1.025 (0.941, 1.116) | 1.015 (0.947, 1.088) |
Discussion
Disclosures and Acknowledgments
References
Alzheimer's Association. 2009 Alzheimer's disease facts and figures. Available from wwwalzorg/national/documents/report_alzfactsfigures2009pdf. Accessed March 18, 2010.
- Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment.JAMA. 2003; 290: 73-80
- Use of feeding tubes in nursing home residents with severe cognitive impairment.JAMA. 2002; 287: 3211-3212
- Barriers to limiting the practice of feeding tube placement in advanced dementia.J Palliat Med. 2003; 6: 885-893
- Acceptability and outcomes of the percutaneous endoscopic gastrostomy (PEG) tube placement—patients' and care givers' perspectives.BMC Gastroenterol. 2006; 24: 6-37
- Expectations and outcomes of gastric feeding tubes.Am J Med. 2006; 119: 527.e11-527.e16
- Survival after percutaneous endoscopic gastrostomy placement in older persons.J Gerontol A Biol Sci Med Sci. 2000; 55: M735-M739
- The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment.Arch Intern Med. 1997; 157: 327-332
- High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding.Arch Intern Med. 2001; 161: 594-599
- Enteral tube feeding for older people with advanced dementia.Cochrane Database Syst Rev. 2009; 15: CD007209
- Factors predictive of survival after percutaneous endoscopic gastrostomy in the elderly: is dementia really a risk factor?.Am J Gastroenterol. 2008; 103: 1011-1016
- Dementia and cognitive impairment are not associated with earlier mortality after percutaneous endoscopic gastrostomy.JPEN J Parenter Enteral Nutr. 2009; 33: 62-66
- Natural history of feeding-tube use in nursing home residents with advanced dementia.J Am Med Dir Assoc. 2009; 10: 264-270
- Malnutrition, tube feeding and pressure sores: data are incomplete.J Am Geriatr Soc. 1995; 43: 447-451
- Rethinking the role of tube feeding in patients with advanced dementia.N Engl J Med. 2000; 342: 206-210
- Hospital characteristics associated with feeding tube placement in nursing home residents with advanced cognitive impairment.JAMA. 2010; 303: 544-550
- The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care.Ann Intern Med. 2003; 138: 288-298
- The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.Ann Intern Med. 2003; 138: 273-287
- Bereaved family member perceptions of quality of end-of-life care in U.S. regions with high and low usage of intensive care unit care.J Am Geriatr Soc. 2005; 53: 1905-1911
- Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure.Circ Cardiovasc Qual Outcomes. 2009; 2: 548-557
- Aggressive treatment style and surgical outcomes.Health Serv Res. 2010; 45: 1872-1892
- Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination.J Gerontol A Biol Sci Med Sci. 1995; 50: M128-M133
- MDS Cognitive Performance Scale.J Gerontol. 1994; 49: M174-M182
- Percutaneous endoscopic gastrostomy and outcome in dementia.Am J Gastroenterol. 2001; 96: 2556-2563
- The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people.J Am Geriatr Soc. 2003; 51: 96-100
- Scaling ADLs within the MDS.J Gerontol A Biol Sci Med Sci. 1999; 54: M546-M553
- Predictors of nursing home hospitalization: a review of the literature.Med Care Res Rev. 2008; 65: 3-39
- Factors differentiating hospital transfers from long-term care facilities with high and low transfer rates.Gerontologist. 1991; 31: 795-806
- Nursing home characteristics and potentially preventable hospitalizations of long-stay residents.J Am Geriatr Soc. 2004; 52: 1730-1736
- Nursing home facility risk factors for infection and hospitalization: importance of registered nurse turnover, administration, and social factors.J Am Geriatr Soc. 2002; 50: 1987-1995
Dartmouth Atlas of Health Care. Available from http://www.dartmouthatlas.org/. Accessed March 18, 2010.
- Tube feeding in patients with advanced dementia: a review of the evidence.JAMA. 1999; 282: 1365-1370
- Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care.JAMA. 2008; 299: 2406-2412
- Hospital quality and intensity of spending: is there an association?.Health Aff (Millwood). 2009; 28: w566-w572
- A map to bad policy–hospital efficiency measures in the Dartmouth Atlas.N Engl J Med. 2010; 362: 569-574
- Looking back, moving forward.N Engl J Med. 2010; 362: 569-574
- Healthcare costs associated with percutaneous endoscopic gastrostomy among older adults in a defined community.J Am Geriatr Soc. 2001; 49: 1525-1529
- Financial incentives for placing feeding tubes in nursing home residents with advanced dementia.J Am Geriatr Soc. 2003; 51: 129-131
- Frailty and hospitalization of long-term stay nursing home residents.J Am Geriatr Soc. 1997; 45: 265-269
- Percutaneous endoscopic gastrostomy in a general hospital: prospective evaluation of indications, outcome, and randomised comparison of two tube designs.Gut. 1994; 35: 1551-1556
- Decision-making and outcomes of feeding tube insertion: a five-state study.J Am Geriatr Soc. 2011; 59: 881-886